A pharmaceutical manufacturer based in the EU that is active in 20+ countries for 20+ years. Key production lines are generic, medical device, OTC, nutraceuticals, and cosmetics. They are produced in GMP-compliant manufacture. Main therapeutic areas include allergology and pulmonology, cardiology, dermatology, and the central nervous system. The main dosage forms are liquid, solid, semi-solid, and sprays.

Established in 2016, this manufacturer specializes in the development, out-licensing, and supply of high-quality generic pharmaceutical products and value-added medicines. As a CTD dossier owner and manufacturer, it ensures compliance with international quality standards. The manufacturer offers a robust supply chain and a comprehensive range of services covering all stages of the pharmaceutical value chain, from product development to regulatory approval and life cycle management. Its product portfolio includes value-added solid dosage forms (tablets and capsules), injectables, oral solutions, and suspensions, with generics suitable for Day 1 launch upon patent expiry. As a CTD dossier owner and manufacturer, its products are distributed across multiple countries worldwide.

Established in 1926, this European pharmaceutical manufacturer specializes in the research, development, production, and marketing of pharmaceutical products. As a CTD dossier owner and manufacturer, it holds GMP certifications from regulatory authorities in Turkey, Azerbaijan, Denmark (EU GMP), Kenya, Russia, Kyrgyzstan, and Libya, ensuring compliance with international quality standards. The company operates advanced production lines with an annual capacity of 40 million packs of solid products, 15 million packs of semi-solid products, 15 million packs of liquid products, and 2 million packs of effervescent granule products, adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed across approximately 150 countries worldwide.